Cite

HARVARD Citation

    Hassan, W. et al. (2016). A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models. Oncology and therapy. 4 (2), pp. 257-274. [Online]. 
  
Back to record